Skip to main content
SpringerLink
Log in

The Mitral Valve Heart Team

  • Chapter
  • First Online:
Heart Teams for Treatment of Cardiovascular Disease

  • 505 Accesses

Abstract

The field of cardiac surgery has drastically changed over the course of half a century. With the implementation of advanced catheter-based techniques, less invasive surgical methods, and generally a sicker population of patients, came a necessary collaboration between disciplines. We have seen this in the treatment of ischemic heart disease and now aortic valve disease. Mitral valve surgery presents a unique population of patients that are both complex and heterogeneous in their pathology. The pathophysiology of these patients may be primarily valvular in origin or secondary to ventricular failure (i.e. functional). In order to determine the safest, most efficacious, and most durable treatment, it is necessary to have a heart team dedicated to the practice. Expertise from cardiologist, interventionalist, advanced anesthesiologist and additional fields become increasingly necessary. The care for this patient population only begins with their evaluation before the invention and endures long after. The literature has demonstrated a disparity in knowledge on the pathophysiology as well as optimal treatment for this cohort. Moreover, the creation of a mitral valve heart team will face significant challenges requiring a change in practitioner culture and even referral pattern. Nevertheless, sharing information between disciplines with an ultimate goal of how best to manage this complex disease is in the foreseeable future. Tracking outcomes and benchmarking institutions with mitral valve heart teams will become the norm.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11.

    Article  Google Scholar 

  2. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91.

    Article  Google Scholar 

  3. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2017;135(25):e1159–95.

    Article  Google Scholar 

  4. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129(23):2440–92.

    Article  Google Scholar 

  5. Lang RM, Addetia K, Narang A, Mor-Avi V. 3-dimensional echocardiography: latest developments and future directions. JACC Cardiovasc Imaging. 2018;11(12):1854–78.

    Article  Google Scholar 

  6. Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303–71.

    Article  Google Scholar 

  7. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352(9):875–83.

    Article  CAS  Google Scholar 

  8. El-Tallawi KC, Messika-Zeitoun D, Zoghbi WA. Assessment of the severity of native mitral valve regurgitation. Prog Cardiovasc Dis. 2017;60(3):322–33.

    Article  Google Scholar 

  9. Verma S, Mesana TG. Mitral-valve repair for mitral-valve prolapse. N Engl J Med. 2009;361(23):2261–9.

    Article  CAS  Google Scholar 

  10. Braunberger E, Deloche A, Berrebi A, Abdallah F, Celestin JA, Meimoun P, et al. Very long-term results (more than 20 years) of valve repair with carpentier’s techniques in nonrheumatic mitral valve insufficiency. Circulation. 2001;104(12 Suppl 1):I8–11.

    Article  CAS  Google Scholar 

  11. Chan V, Ruel M, Chaudry S, Lambert S, Mesana TG. Clinical and echocardiographic outcomes after repair of mitral valve bileaflet prolapse due to myxomatous disease. J Thorac Cardiovasc Surg. 2012;143(4 Suppl):S8–11.

    Article  Google Scholar 

  12. Chikwe J, Toyoda N, Anyanwu AC, Itagaki S, Egorova NN, Boateng P, et al. Relation of mitral valve surgery volume to repair rate, durability, and survival. J Am Coll Cardiol. 2017:pii:S0735-1097(17)30677-0.

    Google Scholar 

  13. Gammie JS, O’Brien SM, Griffith BP, Ferguson TB, Peterson ED. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation. 2007;115(7):881–7.

    Article  Google Scholar 

  14. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364(15):1395–406.

    Article  CAS  Google Scholar 

  15. Messika-Zeitoun D, Nickenig G, Latib A, Kuck KH, Baldus S, Schueler R, et al. Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes. Eur Heart J. 2019;40(5):466–72.

    Article  Google Scholar 

  16. Sorajja P, Mack M, Vemulapalli S, Holmes DR Jr, Stebbins A, Kar S, et al. Initial experience with commercial transcatheter mitral valve repair in the United States. J Am Coll Cardiol. 2016;67(10):1129–40.

    Article  Google Scholar 

  17. Nguyen V, Michel M, Eltchaninoff H, Gilard M, Dindorf C, Iung B, et al. Implementation of transcatheter aortic valve replacement in France. J Am Coll Cardiol. 2018;71(15):1614–27.

    Article  Google Scholar 

  18. Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2013;370(1):23–32.

    Article  Google Scholar 

  19. Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2015;374(4):344–53.

    Article  Google Scholar 

  20. Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379(24):2297–306.

    Article  Google Scholar 

  21. Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, et al. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371(23):2178–88.

    Article  CAS  Google Scholar 

  22. Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379(24):2307–18.

    Article  Google Scholar 

  23. Barbieri A, Bursi F, Grigioni F, Tribouilloy C, Avierinos JF, Michelena HI, et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J. 2011;32(6):751–9.

    Article  Google Scholar 

  24. Enriquez-Sarano M, Suri RM, Clavel MA, Mantovani F, Michelena HI, Pislaru S, et al. Is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation. J Thorac Cardiovasc Surg. 2015;150(1):50–8.

    Article  Google Scholar 

  25. Suri RM, Vanoverschelde JL, Grigioni F, Schaff HV, Tribouilloy C, Avierinos JF, et al. Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets. JAMA. 2013;310(6):609–16.

    Article  CAS  Google Scholar 

  26. Tribouilloy C, Rusinaru D, Grigioni F, Michelena HI, Vanoverschelde JL, Avierinos JF, et al. Long-term mortality associated with left ventricular dysfunction in mitral regurgitation due to flail leaflets: a multicenter analysis. Circ Cardiovasc Imaging. 2014;7(2):363–70.

    Article  Google Scholar 

  27. Dziadzko V, Clavel MA, Dziadzko M, Medina-Inojosa JR, Michelena H, Maalouf J, et al. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet. 2018;391(10124):960–9.

    Article  Google Scholar 

  28. Iung B, Delgado V, Lazure P, Murray S, Sirnes PA, Rosenhek R, et al. Educational needs and application of guidelines in the management of patients with mitral regurgitation. A European mixed-methods study. Eur Heart J. 2018;39(15):1295–303.

    Article  Google Scholar 

  29. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16(1):9–13.

    Article  CAS  Google Scholar 

  30. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734–44.

    Article  Google Scholar 

  31. O’Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery. Ann Thorac Surg. 2009;88(1 Suppl):S23–42.

    Article  Google Scholar 

  32. Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg. 1999;15(6):816–22.

    Article  CAS  Google Scholar 

  33. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Detaint D, Vanoverschelde JL, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28(11):1358–65.

    Article  Google Scholar 

  34. Lancellotti P, Rosenhek R, Pibarot P, Iung B, Otto CM, Tornos P, et al. ESC working group on valvular heart disease position paper—heart valve clinics: organization, structure, and experiences. Eur Heart J. 2013;34(21):1597–606.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada

    David Messika-Zeitoun

  2. University of Connecticut Health, Department of Surgery, Farmington, CT, USA

    Anthony Tran

  3. Department of Medicine, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada

    Benjamin Hibbert

  4. Department of Surgery, University of Ottawa Heart Institute, Ottawa, ON, Canada

    Vincent Chan

Authors
  1. David Messika-Zeitoun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony Tran
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Benjamin Hibbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vincent Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Messika-Zeitoun .

Editor information

Editors and Affiliations

  1. University of Ottawa Heart Institute, Ottawa, ON, Canada

    Thierry Mesana

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Messika-Zeitoun, D., Tran, A., Hibbert, B., Chan, V. (2019). The Mitral Valve Heart Team. In: Mesana, T. (eds) Heart Teams for Treatment of Cardiovascular Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-19124-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-19124-5_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-19123-8

  • Online ISBN: 978-3-030-19124-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation